Label: 7030 CALCIUM PREMIUM- calcium capsule
- NDC Code(s): 55259-1112-1
- Packager: Apexel Co., Ltd
- Category: HUMAN OTC DRUG LABEL
- DEA Schedule: None
- Marketing Status: unapproved drug other
DISCLAIMER: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.
Drug Label Information
Updated January 23, 2024
If you are a consumer or patient please visit this version.
- Download DRUG LABEL INFO: PDF XML
- Official Label (Printer Friendly)
- ACTIVE INGREDIENT
- INACTIVE INGREDIENT
- PURPOSE
- KEEP OUT OF REACH OF CHILDREN
- INDICATIONS & USAGE
- WARNINGS
- DOSAGE & ADMINISTRATION
- PRINCIPAL DISPLAY PANEL
-
INGREDIENTS AND APPEARANCE
7030 CALCIUM PREMIUM
calcium capsuleProduct Information Product Type HUMAN OTC DRUG Item Code (Source) NDC:55259-1112 Route of Administration ORAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength CALCIUM (UNII: SY7Q814VUP) (CALCIUM - UNII:SY7Q814VUP) CALCIUM 0.99 mg Inactive Ingredients Ingredient Name Strength MAGNESIUM (UNII: I38ZP9992A) ZINC OXIDE (UNII: SOI2LOH54Z) SELENIUM (UNII: H6241UJ22B) GERMANIUM (UNII: 00072J7XWS) IRON (UNII: E1UOL152H7) POTASSIUM (UNII: RWP5GA015D) MANGANESE (UNII: 42Z2K6ZL8P) Product Characteristics Color white (white) Score no score Shape OVAL (tablet) Size 12mm Flavor Imprint Code 3;hp;x Contains Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:55259-1112-1 120 in 1 PACKAGE; Type 0: Not a Combination Product 03/18/2021 Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date unapproved drug other 03/18/2021 Labeler - Apexel Co., Ltd (687287979) Registrant - Apexel Co., Ltd (687287979) Establishment Name Address ID/FEI Business Operations Apexel Co., Ltd 687287979 manufacture(55259-1112)